Mounjaro Kwikpen Test
Mounjaro is a medication for improving blood sugar control in adults with type 2 diabetes and for weight loss in those with obesity or overweight conditions. It contains tirzepatide, a GLP-1 and GIP agonist, administered weekly via injection.
- The description claims that Mounjaro improves blood sugar control in adults with type 2 diabetes.
- The description claims that Mounjaro can be used for weight loss in adults with obesity (BMI≥30) or overweight (BMI≥27) with a weight-related condition.
- The description claims that tirzepatide acts like GLP-1 and GIP hormones to lower blood sugar levels and decrease appetite.
- The description claims that tirzepatide slows down food movement through the body, helping to stay full longer.
Specifications
- Choose Strength
- 2.50mg, 5.00mg, 7.50mg, 10.00mg, 12.50mg, 15.00mg
Variants (6)
- 2.50mg — 189.00 GBP — In stock
- 5.00mg — 199.00 GBP — In stock
- 7.50mg — 259.00 GBP — In stock
- 10.00mg — 289.00 GBP — In stock
- 12.50mg — 309.00 GBP — In stock
- 15.00mg — 329.00 GBP — In stock
AI Readiness
Good foundation, but some important product data is still missing.
84%